Novo has long sold a separate version of oral semaglutide for diabetes under the brand name Rybelsus, which the medicine ...

Central to the new report (PDF) are the JEC Democrats' findings that Trump increased his stock holdings in the pharmaceutical ...

In this week's episode of "The Top Line," we're looking at two companies building on recent successes and pursuing new ...

In the fiercely competitive inflammatory bowel disease (IBD) market, Eli Lilly is making the case for its antibody Omvoh as a ...

Sanofi is gearing up for another major sports sponsorship in its home country, this time with the 2027 Tour de France. | The ...

Hot off a pair of key FDA green lights this summer, rare disease specialist Ultragenyx has wasted little time cashing in a ...

U.S.-based generic drugmaker Par Health has issued a voluntary recall of 22 lots of the direct thrombin inhibitor argatroban ...

Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into ...

Some six years after scoring an initial FDA nod in neuromyelitis optica spectrum disorder, Roche’s IL-6 receptor agonist ...

Expanding its presence in dermatology, Cetaphil maker Galderma has agreed to acquire professional skincare shop Zo Skin ...

Drug-device maker Kaléo has secured a federal contract worth $96.1 million, enlisting in an effort to bolster U.S. biodefense ...

As the momentum continues to pick up at NorthStar Medical Technologies, the radioisotope producer is strengthening ties in ...